Temasek
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Isomorphic Labs raises £1.5bn Series B led by Thrive Capital for AI models that design new drug candidates
Isomorphic Labs develops AI models for drug discovery and drug design across multiple therapeutic areas and drug types. IsoDDE helps researchers predict biological systems and identify potential drug candidates for pharmaceutical development.
Tropic secures £80m Series C led by Forbion and Corteva for gene-edited tropical crop varieties
Tropic develops gene-edited tropical crop varieties designed to improve disease resistance, shelf life and agricultural productivity. Its products aim to help growers, exporters and food supply chains manage crop disease, reduce waste and increase yields.
CuspAI raises £75m Series A led by NEA and Temasek to accelerate AI-driven materials discovery
CuspAI applies generative AI and physics based simulation to design new materials, helping customers discover compounds faster for applications in energy, climate, computing and manufacturing.
PhysicsX raises £100m in Series B led by Atomico to scale AI-native engineering software for manufacturing industries
PhysicsX builds AI-native engineering software that accelerates the design, simulation and operation of complex physical systems, supporting advanced manufacturing across aerospace, automotive, energy and materials industries.
More venture news
- 3 Jun 2026
Wordsmith AIWordsmith raises £55m Series B from Highland Europe and Index Ventures to bring end-to-end operations platform to in-house legal teams
Series BLegal - 28 May 2026
Orbital IndustriesOrbital Industries lands £37m Series B led by Plural to build data centre hardware with AI model
Series BAI - 20 May 2026
RemotePassRemotePass unlocks £13m Series B led by EBRD VC for cross-border payroll and workforce management platform
Series BEnterprise
